SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

PLoS One. 2019;14(1):e0210703.

Trends in emergency department visits and hospitalization rates for inflammatory bowel disease in the era of biologics.

, , , , , , ,

제1저자 허건 · 교신저자 윤혁

소속 (2)
  1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
  2. Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

Abstract

BACKGROUND The use of biologics in inflammatory bowel disease (IBD) has increased recently. However, studies on whether the proportion of IBD patient visits to the emergency department (ED) has decreased are scarce. We investigated the trends in IBD-related ED visits and hospitalization rates.

METHODS Medical records of IBD-related visits to the ambulatory department (AD) and the ED of the Seoul National University Bundang Hospital in 2007, 2009, 2012, and 2014 were reviewed. Multiple-variable logistic regression analysis was used to identify significant risk factors for hospitalization.

RESULTS The proportion of IBD patients who visited ED was 12.3% in 2007, 9.7% in 2009, 8.3% in 2012, and 6.4% in 2014 (P = 0.002). The most common chief complaints were abdominal pain (66.9%) in Crohn's disease (CD) patients and hematochezia (36.5%) in ulcerative colitis (UC) patients. The hospitalization rate following ED visits was 47.2% in CD patients and 55.6% in UC patients (P = 0.100). Multiple-variable analysis showed that significant risk factors associated with hospitalization in CD were aggressive disease behavior (odds ratio[OR] 3.54, P = 0.017) and presence of steroid exposure (OR 2.35, P = 0.047). Elevated C-reactive protein (CRP) (>0.5 mg/dL) (OR 5.40, P = 0.016) was the only risk factor associated with hospitalization in UC.

CONCLUSIONS The proportion of ED visits decreased from 2007 to 2014; there was no significant change in hospitalization rates. Disease behavior/presence of steroid exposure and elevated CRP were associated with hospitalization among CD and UC patients who visited the ED, respectively.

Figures

Fig 1
Fig 1 The number and proportion of patients with IBD (A), CD (B), and UC (C) visiting ED and AD stratified by years. The absolute number of IBD patients who visited ED increased but the ED proportion of total patients decreased from 2007 to 2014 (linear-by-linear P = 0.002).
Fig 2
Fig 2 Hospitalization rates of patients with IBD (A), CD (B), and UC (C) visiting ED stratified by years. There was no significant linear trend for hospitalization rates of ED patients (P = 0.610).
Fig 3
Fig 3 The number and proportion of patients with IBD (A), CD (B), and UC (C) treated with biologics stratified by years. The number and proportion of IBD patients who had received or under treatment with biologics increased from 2007 to 2014 (P <0.001).
Fig 4
Fig 4 Length of hospitalization stay according to disease behavior in CD patients. The length of hospitalization stay was longer in patients with B3 than in patients with B1 or B2.

그림 출처: PubMed Central 공개 논문 (PMC6334964)

Comment · 정정

Conflict of interest statement

The authors have declared that no competing interests exist.

그 밖의 정보
출판 형태
Journal Article
저널
PloS one · eISSN 1932-6203
전자 출판
2019-01-16
MeSH
Adult · Colitis, Ulcerative / epidemiology · Crohn Disease / epidemiology · Emergency Service, Hospital / statistics & numerical data / trends · Female · Hospitalization / statistics & numerical data / trends · Humans · Inflammatory Bowel Diseases / epidemiology · Male · Middle Aged · Young Adult
참고문헌
21편